Symbiotec Pharmalab Shares Surge 6% After Subsidiary Secures U.S. Distribution Rights for Injectable Products
Symbiotec Pharmalab shares rose roughly 6% on Thursday, October 1, after investors reacted to a distribution‑rights announcement from its wholly‑owned subsidiary, Knovea Pharmaceutical. The filing, ma...